Combination drug
Drug with two or more active ingredients
From Wikipedia, the free encyclopedia
A combination drug is most simply defined as a chemical composition of at least two drugs combined in a single dosage form, typically as a tablet or capsule to be administered orally, an elixir or tincture (sublingual), an injectable suspension (intramuscular administration or intravenous therapy), or a suppository (rectal). A legitimate combination drug that exceeds rigorous laboratory quality standards and is approved for medical use is a safe option for treating multiple symptoms or diseases amongst various patients within a large population–and this includes combinations of over-the-counter medicine and/or of prescription drugs. When medications are paired with supplements, consumers can be certain of accurate dosing and ingredient labeling, as well as product quality as it would be regulated and manufactured as a medication and must meet rigorous standards of pharmaceutical quality.
A polypill is a pill containing four or more active ingredients,[1][2] often produced at a compounding pharmacy due to the specific dosage, dosage form, and modified release mechanism. Polypills can encompass four or more of any combination of approved prescription drugs and over the counter drugs, as well as nutritional supplements and hormones, amino acids, enzymes, vitamins, and/or essential minerals.[3]
History
Fixed-dose combination drugs were initially developed to target a single disease, as with antiretroviral FDCs indicated for treating AIDS and HIV.[4] Combination drug treatment conceptually emphasizes simplified treatment plans, reduced pill burden and increased patient compliance by offering accessible and affordable ingredients, generally generic drugs with established therapeutic efficacy, and the ability to treat a variety of symptoms and conditions amongst a large patient population with varying treatment needs.
Combination legend drugs
The following are generally available as legend drugs, typically availably by prescription.[clarification needed]
The combination drugs listed below are universally available by prescription only, but specific circumstances regarding a given combination's legal accessibility, or any specific regulation pertinent to ingredient quality, quantities, production standards, sourcing, etc. will vary by jurisdictions, and include:[5]
- amitriptyline/perphenazine (Triavil), amitriptyline/chlordiazepoxide (Limbitrol-H),[6][7][8] and Bangladesh
- amlodipine/benazepril (Lotrel), amlodipine/atorvastatin (Conduet),
- amlodipine/celecoxib (Consensai)
- lisinopril/amlodipine (Lisonorm),
- amlodipine/olmesartan
- amlodipine/valsartan (Exforge)
- amphetamine racemic salt mixture (dextroamphetamine as sulfate and saccharate, levoamphetamine as sulfate and aspartate monohydrate) (Adderall)
- bupropion/naltrexone (Contrave)
- butalbital and caffeine (Butapap); butalbital, caffeine, and either aspirin (Fiorinal) or acetaminophen (Fioricet), Fioricet with Codeine
- calcipotriol/betamethasone dipropionate, Dovobet by LEO Pharma.
- carbidopa/levodopa/entacapone (LCE), Stalevo, Lecigon for infusion therapy in some European countries
- chlordiazepoxide and clidinium bromide[9][10]
- ephedrine/ethylmorphine
- flupentixol/melitracen, available in Bangladesh as Deanxit by Lundbeck
- hydrocodone/acetaminophen[11] LorTab by UCB is now solely available as a syrup in the U.S.[12]
- hydrocodone and aspirin, Azdone
- hydrocodone and guaifenesin (expectorant), Obedron, Flowtuss
- hydrocodone and ibuprofen (nonsteroidal anti-inflammatory]])NSAID), Ibudone
- ibuprofen and acetaminophen intravenous solution, ibuprofen/paracetamol (Maxigesic IV[13]
- nirmatrelvir (antiviral) and ritonavir (antiviral), combination drug for treatment and management of COVID-19), Paxlovid[14]
- omeprazole/amoxicillin/rifabutin
- olanzapine/fluoxetine
- oxycodone/acetaminophen (Percocet)
- oxycodone/aspirin (Percodan)
- oxycodone/ibuprofen (Combunol)
- phentermine/topiramate (Qsymia)
- phenylephrine/ketorolac (Omidria)[15]
- pseudoephedrine/carbinoxamine (Rondec) elixir[16]
- Propyphenazone/paracetamol/caffeine[citation needed]
- tramadol/paracetamol[citation needed]
Combination drugs accessible over the counter
Combination drugs are sold over the counter in some countries. In the United States, products containing the active ingredient ephedrine, pseudoephedrine, or phenylpropanolamine are stored behind the pharmacy counter and can be purchased without a medical prescription, albeit subject to U.S. Federal drug law recordkeeping requirements as required by the Combat Methamphetamine Epidemic Act of 2005.[17] The following combination drugs are accessible OTC in nearly all locations:
- aspirin/paracetamol (Anacin)[18] and aspirin/paracetamol/caffeine (Excedrin)[19]
- Various cough medicines combine: dextromethorphan, acetaminophen, chlorpheniramine, doxylamine succinate, phenylpropanolamine, pseudoephedrine, guaifenesin, etc. (Robitussin, Coricidin, Altec, Rondec)[20][21][22][23]
- diphenhydramine/dimenhydrinate (Dramamine)[24][25]
- fenproporex/diazepam (Esbelcaps), available in Central America and Paraguay; discontinued in Brazil[26]
- fexofenadine/pseudoephedrine (Allegra-D)
- glucose/fructose/phosphoric acid (Emetrol for Nausea)
- guaifenesin/phenylephrine (Sudafed PE)
- ibuprofen/famotidine (Duexis)[27] and ibuprofen/diphenhydramine (Advil PM); acetaminophen/diphenhydramine (Tylenol PM)
- loratadine/pseudoephedrine (Claritin-D)
- naproxen/diphenhydramine (Aleve PM)[28] and naproxen/pseudoephedrine (Aleve-D)
- oxomemazine/guaifenesin (Toplexil by Aventis), available in France, Algeria, and Morocco[29]
Combination drugs under development
- MDMA/citalopram, entactogen and SSRI antidepressant in Phase II clinical trials for treating post-traumatic stress disorder.[30]
Combination drugs for veterinary use
- Temaril-P combines alimemazine (antitussive) and prednisolone (antipruritic), approved for use in dogs, generic drug since 2024, and substitutes alimemazine for trimeprazine, leaving in place prednisolone, equivalent to branded formula in efficacy
- Titzeol combines tiletamine and zolazepam, large animal tranquilizer[31]
Widely discontinued formulations
Several fixed-dose combination drugs marketed in the mid-20th century were later withdrawn due to safety concerns, changing regulatory standards, or abuse potential. Notable examples include:
- Dexamyl – a combination of dextroamphetamine and amobarbital, used as a stimulant-sedative preparation, withdrawn in the early 1980s.
- Tuinal – a combination of two barbiturates, amobarbital and secobarbital, prescribed as a sedative and hypnotic; it became notable both for medical use and recreational abuse. * Ethobral by Wyeth combined secobarbital, butabarbital, and phenobarbital[32][33]
- Anox (Anox Diacels) – a triple barbiturate plus stimulant combination (phenobarbital, butabarbital, secobarbital, with methamphetamine and dextroamphetamine), reflecting the mid-century trend of “upper-lower” formulations.[34]
- Fenfluramine/phentermine (fen-phen) – an appetite suppressant combination withdrawn in 1997 after reports of cardiac valve toxicity.[35]
- Mandrax and Durophet – a combination of methaqualone and diphenhydramine, widely used recreationally in South Africa until 1993.
- Obetrol and Biphetamine – mixed amphetamine salts used historically for obesity and attention disorders.
- Eskatrol – combined dextroamphetamine with prochlorperazine, historically prescribed for appetite suppression.
- Amfecloral (dextroamphetamine/chloral hydrate) discontinued 1973[36]
- [37] Obocell[38][39][40][41]) combined 10 mg dextroamphetamine tannate with 35 mg secobarbital[42]
These examples illustrate a period when pharmaceutical companies marketed combination drugs to address multiple therapeutic effects simultaneously, often combining stimulants and sedatives in the same formulation. Many such products were eventually withdrawn due to safety, abuse potential, or evolving regulatory standards.[43][44]
Justification of medical use
Fixed-dose combination drugs are used to simplify treatment regimens by delivering multiple active ingredients in a single dosage form. This approach may reduce pill burden, improve medication adherence, and enhance convenience for patients with chronic conditions, though combination products also have limitations. The fixed ratio of ingredients may restrict dose adjustment for individual components, and contraindication to one constituent may preclude use of the entire product. Formulation can also present technical challenges, including compatibility, stability, and dissolution differences among active ingredients and excipients.[45]
Illicit or informal combinations
Outside regulated pharmaceutical products, some illicit drugs are distributed or consumed as mixtures of multiple psychoactive substances. Examples include cocaine adulterated with levamisole, counterfeit opioid tablets containing fentanyl or other synthetic opioids, and “Mandrax,” a preparation combining methaqualone and diphenhydramine. Such products are not standardized and may contain unpredictable quantities of their components. The veterinary anthelmintic levamisole has been widely detected as an adulterant in cocaine supplies and has been associated with serious adverse effects such as agranulocytosis and vasculitis.[46]
Following the closure of numerous pill mill operations in the United States beginning in the late 2000s, the illicit opioid market expanded substantially.[47] Counterfeit tablets sold as prescription opioids are often manufactured illicitly and may contain undeclared quantities of highly potent synthetic opioids, including fentanyl, carfentanil, and nitazenes [citation needed]. Additional adulterants reported in illicit drug supplies include the veterinary sedative xylazine and triazolobenzodiazepines such as bromazolam or phenazolam..[citation needed] Xylazine has been scheduled as a controlled substance in several U.S. states and has been considered for federal regulation.[48][49][50] In April 2025, U.S. Attorney General Pam Bondi stated a desire to regulate xylazine under U.S. federal drug law) as a Schedule III controlled substance.[51] Xylazine is currently a controlled substance under state statutes in Michigan and New York.[52]
